European principles of inhibitor management in patients with haemophilia: implications of new treatment options von Hermans, C., Giangrande, P. L. F., O'Mahony, B., de Kleijn, P., Bedford, M., Batorova, A., Blatny, J., Jansone, K.

Volltext

Haemophilia care in Europe - a survey of 35 countries von O'Mahony, B., Noone, D., Giangrande, P. L. F., Prihodova, L.

Volltext

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99 von Darby, S. C., Keeling, D. M., Spooner, R. J. D., Wan Kan, S., Giangrande, P. L. F., Collins, P. W., Hill, F. G. H., Hay, C. R. M.

Volltext

Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentrates von Giangrande, P. L. F., Peyvandi, F., O'Mahony, B., Behr‐Gross, M.‐E., Hilger, A., Schramm, W., Mannucci, P. M.

Volltext

Haemophilia Care in Europe: the ESCHQoL study von Schramm, W., Gringeri, A., Ljung, R., Berger, K., Crispin, A., Bullinger, M., Giangrande, P. L. F., Von Mackensen, S., Mantovani, L. G., Nemes, L., Serban, M.

Volltext

Consensus perspectives on prophylactic therapy for haemophilia: summary statement von Berntorp, E., Astermark, J., Björkman, S., Blanchette, V. S., Fischer, K., Giangrande, P. L. F., Gringeri, A., Ljung, R. C., Manco-Johnson, M. J., Morfini, M., Kilcoyne, R. F., Petrini, P., Rodriguez-Merchan, E. C., Schramm, W., Shapiro, A., M. Van Den Berg, H., Hart, C.

Volltext

Management of difficult-to-treat inhibitor patients von GIANGRANDE, P. L. F., ESCOBAR, M. A.

Volltext

Treatment of patients with haemophilia and inhibitory antibodies von GIANGRANDE, P. L. F

Volltext

Treatment of hemophilia: recombinant factors only? Yes von Giangrande, P. L. F.

Volltext

Adverse events in the prophylaxis of haemophilia von Giangrande, P. L. F.

Volltext

Achievement of immune tolerance in a patient with haemophilia B and inhibitory antibodies, complicated by an anaphylactoid reaction von CURRY, N. S., MISBAH, S. A., GIANGRANDE, P. L. F., KEELING, D. M.

Volltext

Choice of replacement therapy for hemophilia—a rebuttal von Giangrande, P. L. F.

Volltext

Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease von Sukhu, K., Poovalingam, V., Mahomed, R., Giangrande, P. L. F

Volltext

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C von Darby, Sarah C, Ewart, David W, Giangrande, Paul LF, Spooner, Rosemary JD, Rizza, Charles R, Dusheiko, Geoffrey M, Lee, Christine A, Ludlam, Christopher A, Preston, F Eric

Volltext

Evaluation of a novel ELISA screening test for detection of factor VIII inhibitory antibodies in haemophiliacs von Martin, P. G., Sukhu, K., Chambers, E., Giangrande, P. L. F.

Volltext

Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population von UK Haemophilia Centre Directors' Organisation, Darby, IsC, Ewart, D.W, Giangrande, I.P.L.F, Spooner, R.J.D, Rizza, C.R

Volltext

Treatment of haemophilia in the United Kingdom 1981-1996 von Rizza, C R, Spooner, R J, Giangrande, P L

Volltext

Increased bleeding associated with protease inhibitor therapy in HIV‐positive patients with bleeding disorders von Wilde, Jonathan T., Lee, Christine A., Collins, Peter, Giangrande, Paul L. F., Winter, Mark, Shiach, Caroline R.

Volltext

Mortality before and after HIV infection in the complete UK population of haemophiliacs von Darby, Sarah C, Ewart, David W, Giangrande, Paul L. F, Dolin, Paul J, Spooner, Rosemary J. D, Rizza, Charles R

Volltext

HEPATITIS IN HAEMOPHILIA von Giangrande, Paul L. F.

Volltext